Read-only by design — Olmem never buys, sells, shorts, or places any order. This platform provides market research and decision-support tools only. It does not provide personalized financial advice, does not guarantee investment results, and does not execute trades. All investment decisions are the responsibility of the user.
← Scanner

AAgilent Technologies, Inc.

Healthcare·Diagnostics & Research·NYSE·Mkt cap $38.00B
$109.06
$0.93 (+0.86%) today
IEX feed · not consolidated
Last updated Oct 19, 2:15 PM
51/100 Opportunity
44Risk
49Momentum
62Pullback
65Quality
68Valuation
0Trend
Price & History (up to 5 years)
2022-11-09 → 2023-11-09
Low 99.01— support · — resistanceHigh 154.81
Technical Indicators
RSI (14)46.4
MACD hist0.34
ATR (14)2.49
SMA 20108.71
SMA 50113.81
SMA 200126.82
Rel volume0.9x
Boll upper110.88
Boll lower106.55
52w high155.36
52w low105.25
5y high159.82
5y low105.25
Hist. vol28%
Max drawdown-31%
Near Five-Year LowNeutral MomentumPossible Dip BuyEntry: Pullback Watch
Company QualityStable
Revenue growth+8.0%
Earnings growth+10.0%
Profit margin+16.0%
ROE+20.0%
Debt/Equity0.60
Free cash flow—
P/E22.0
Fwd P/E18.0
P/S4.0
P/B4.5
Div yield+1.5%

Agilent Technologies, Inc. — Diagnostics & Research company in the Healthcare sector.

Decision SummaryInternal Rule-Based Analysis
Current Rating
Weak Setup
Opportunity Score
51/100
Risk Level
Moderate
Best Action
Add to watchlist and monitor for confirmation

Why: A is trading near recent levels (+0.9% today). Overall, the company is reasonably solid. It is near its five-year low, so the reason for the decline must be examined carefully before assuming value. Short-term momentum is still weak, so confirmation is needed before acting. This may be worth monitoring, but confirmation is needed before acting.

What to watch: Volume confirmation, hold of nearest support, next earnings date, sector strength, and news sentiment.

Avoid if: Price breaks below support on heavy volume or company guidance weakens.

Internal Rule-Based Analysis · Learning From Historical Outcomes. This rating comes from Olmem’s internal scoring and historical pattern tracking. It is not a guaranteed prediction.

Research only — not financial advice. Olmem never executes trades.

All Scores
Company Quality65
Historical Context30
Valuation68
Trend0
Momentum49
Pullback62
News Sentiment50
Business Move50
Sector Strength55
Risk/Reward100
Entry Timing55
Sell Risk56
Risk44

News & business-move scores come from Olmem’s rule-based news engine (keyword-classified headlines) — no AI. They default to a neutral 50 when there is no recent news.

Recent Signals
  • Near Five-Year LowA is within 3.6% of its 5-year low.